Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy.
about
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsAn open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury.Adverse Events in Treating Smear-Positive Tuberculosis Patients in China.
P2860
Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Early changes in hepatic funct ...... sed anti-tuberculosis therapy.
@en
type
label
Early changes in hepatic funct ...... sed anti-tuberculosis therapy.
@en
prefLabel
Early changes in hepatic funct ...... sed anti-tuberculosis therapy.
@en
P2093
P2860
P1476
Early changes in hepatic funct ...... sed anti-tuberculosis therapy.
@en
P2093
Alice Tang
C Chandrasekar
C Padmapriyadarsini
C Ponnuraja
Christine Wanke
Elizabeth Hannah
G Narendran
Hemanth Kumar
P K Bhavani
P2860
P304
P356
10.1016/J.IJID.2013.08.006
P577
2013-09-13T00:00:00Z